Eisai to buy biotech Morphotek
March 23, 2007Sales and Marketing Eisai, biotech
Eisai is to acquire Morphotek for $325 million, making it the latest pharma company to buy outright a biotech company …
AstraZeneca’s pipeline suffers another blow
March 23, 2007Research and Development
AstraZeneca seems likely to abandon another of its drug projects in what is the latest major late-stage failure to have …
European News Roundup
March 23, 2007Sales and Marketing
Datamonitor reports on the European market:Lilly withdraws EU Arxxant applicationEli Lilly has withdrawn a marketing application for diabetic retinopathy drug …
US News Roundup
March 23, 2007Sales and Marketing
Datamonitor reports on the American market:FDA grants Ranbaxy tentative approval for insomnia drugRanbaxy has received tentative approval from the FDA …
Schering acquisition boosts Bayer’s 2006 turnover figures
March 22, 2007Sales and Marketing
Bayer HealthCare's turnover rose 46% to €11.7 billion on the back of Bayer Group's acquisition of Schering last year. As …
Shire to raise Alzheimer’s awareness
March 21, 2007Medical Communications
Shire Pharmaceuticals has appointed PR and med ed firm hsdcommunications to help raise awareness of its Alzheimer's treatment Reminyl.The specialty …
BMS expands Indian biotech collaboration
March 21, 2007Research and Development BMS, India
Bristol-Myers Squibb will establish a new integrated drug development facility in Bangalore as part of an expansion of its R&D …
Servier “named and shamed” for sales slides
March 21, 2007Sales and Marketing ethics
Servier has been publicly "named and shamed" for using inappropriate materials to train its sales reps.Servier and another company, Shire …
Schering-Plough to buy Organon for 11 billion euros
March 21, 2007Sales and Marketing Merck, Schering-Plough
Schering-Plough is to buy Organon BioSciences by the end of this year, in an €11 billion cash deal.The acquisition will …
Abbott withdraws HIV drugs from Thailand after patent row
March 21, 2007Sales and Marketing HIV
Abbott Laboratories' tit-for-tat decision to withold new HIV treatments from Thailand has drawn an angry response from the Aids Healthcare …
Tyverb gains first approval in US
March 14, 2007Sales and Marketing breast cancer
GlaxoSmithKline's breast cancer drug, Tyverb, has been approved in the US and could help women who have failed to respond …
New diabetes drug launched in UK
March 14, 2007Sales and Marketing Byetta, diabetes
A new diabetes medicine, which mimics the body's natural processes for controlling blood sugar, has been launched in the UK.The …
Pharmafocus Europe
March 12, 2007Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Europe, Pharmafocus
Pharmafocus Europe is a new publication set to become an indispensable business tool for pharmaceutical industry executives with an interest …
Shire dispels doubts about New River acquisition
March 12, 2007Sales and Marketing
Shire has dismissed claims its acquisition of New River Pharmaceuticals is in doubt, after reports that a rival bid for …
Making your mark in 100 days
March 12, 2007Business Services management, recruitment
Congratulatons, you've got the job – you're a senior executive – maybe even the chief executive officer. It's the opportunity …
NICE judges Tarceva too expensive for NHS
March 9, 2007Sales and Marketing Tarceva, lung cancer
Roche's cancer drug Tarceva has been rejected by NICE for use against the most common form of lung cancer.The watchdog …
Huntsworth makes US acquisition
March 9, 2007Medical Communications
Communications group Huntsworth Health has acquired US agency Dorland Global Corporation, extending its reach into the world's largest pharmaceutical market.Dorland …
Doctors reassured by hospital reconfiguration report
March 9, 2007The BMA has said it is "reassured" by Sir Ian Carruthers' report on hospital reconfiguration – the controversial measure which …
Trading Places
March 9, 2007Business Services, Medical Communications, Sales and Marketing AstraZeneca, Athena, public relations, recruitment
Athena Medical PR and AstraZeneca UK have joined forces to undertake a ground-breaking secondment initiative to help build broader expertise …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
